跳至主要内容
临床试验/CTRI/2020/03/024370
CTRI/2020/03/024370尚未招募2 期

Randomized Controlled trial to evaluate efficacy of Aaragwadhadi Lepa followed by Patolmooladi Kashay orally in dadru w.s.r. T.Corporis

Dr Prajakta Prabhakar Kulkarni0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with the symptoms of Dadru-
  • change in colour
  • erythmatous papulovesicular lesion
  • Subjects who are willing to involve in the study and give informed consent in written
  • subjects having positive Microscopic examination of skin scrapping in KOH solution for fungal study

排除标准

  • Any underlying uncontrolled medical illness including diabetes mellitus
  • hypertension
  • liver disorder
  • history of chronic alcoholism
  • severe cardiovascular and pulmonary disorder (where steroid treatment is required)
  • cerebral neurological disease
  • psychiatric diseases
  • Subjects currently recieving drugs like B- blockers, antimalarials and NSAIDs or
  • using corticosteroids and anti-inflammatory medicines until 15 days before inclusion
  • into the study
  • Subjects with history of cancer including skin cancer
  • Skin disorders other than Dadru will be excluded
  • Pregnant female
  • Patients having diarrhoea
  • bleeding piles

研究者

发起方
Dr Prajakta Prabhakar Kulkarni

相似试验